Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-25-001200·BlackRock, Inc.
Schedule 13G ownership disclosure
Cytek Biosciences Inc
Common Stock · CUSIP: 23285D109
Event date: 2024-12-31
- Filing-level shares
- 18,482,795
- Percent of class
- 14.3%
- BlackRock, Inc.
Shares: 18,482,795 · Class: 14.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-001200
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership